310 related articles for article (PubMed ID: 27837276)
1. New-onset diabetes mellitus after living-donor liver transplantation: association with graft synthetic function.
Yagi S; Kaido T; Iida T; Yoshizawa A; Okajima H; Uemoto S
Surg Today; 2017 Jun; 47(6):733-742. PubMed ID: 27837276
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors for new-onset diabetes in living-donor liver transplant recipients.
Honda M; Asonuma K; Hayashida S; Suda H; Ohya Y; Lee KJ; Yamamoto H; Takeichi T; Inomata Y
Clin Transplant; 2013; 27(3):426-35. PubMed ID: 23464510
[TBL] [Abstract][Full Text] [Related]
3. Diabetes mellitus after living donor liver transplantation: data from mainland China.
Zhao J; Yan L; Li B; Zeng Y; Wen T; Zhao J; Wang W; Xu M; Yang J; Ma Y; Chen Z; Wu H; Wei Y
Transplant Proc; 2009 Jun; 41(5):1756-60. PubMed ID: 19545722
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for development of new-onset diabetes mellitus and progressive impairment of glucose metabolism after living-donor liver transplantation.
Abe T; Onoe T; Tahara H; Tashiro H; Ishiyama K; Ide K; Ohira M; Ohdan H
Transplant Proc; 2014 Apr; 46(3):865-9. PubMed ID: 24767367
[TBL] [Abstract][Full Text] [Related]
5. Defining long-term outcomes with living donor liver transplantation in North America.
Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
[TBL] [Abstract][Full Text] [Related]
6. New-onset diabetes after transplantation: drug-related risk factors.
Santos L; Rodrigo E; Piñera C; Quintella E; Ruiz JC; Fernández-Fresnedo G; Palomar R; Gómez-Alamillo C; de Francisco A; Arias M
Transplant Proc; 2012 Nov; 44(9):2585-7. PubMed ID: 23146462
[TBL] [Abstract][Full Text] [Related]
7. New-onset diabetes after liver transplantation and its impact on complications and patient survival.
Lv C; Zhang Y; Chen X; Huang X; Xue M; Sun Q; Wang T; Liang J; He S; Gao J; Zhou J; Yu M; Fan J; Gao X
J Diabetes; 2015 Nov; 7(6):881-90. PubMed ID: 25676209
[TBL] [Abstract][Full Text] [Related]
8. Hypomagnesemia and the risk of new-onset diabetes after liver transplantation.
Van Laecke S; Desideri F; Geerts A; Van Vlierberghe H; Berrevoet F; Rogiers X; Troisi R; de Hemptinne B; Vanholder R; Colle I
Liver Transpl; 2010 Nov; 16(11):1278-87. PubMed ID: 21031543
[TBL] [Abstract][Full Text] [Related]
9. Pretransplant risk factors for new-onset diabetes mellitus after transplant in pediatric liver transplant recipients.
Kuo HT; Lau C; Sampaio MS; Bunnapradist S
Liver Transpl; 2010 Nov; 16(11):1249-56. PubMed ID: 21031540
[TBL] [Abstract][Full Text] [Related]
10. Higher tacrolimus blood concentration is related to increased risk of post-transplantation diabetes mellitus after living donor liver transplantation.
Song JL; Li M; Yan LN; Yang JY; Yang J; Jiang L
Int J Surg; 2018 Mar; 51():17-23. PubMed ID: 29360611
[TBL] [Abstract][Full Text] [Related]
11. Predictors of new onset diabetes after renal transplantation.
Joss N; Staatz CE; Thomson AH; Jardine AG
Clin Transplant; 2007; 21(1):136-43. PubMed ID: 17302602
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for new-onset diabetes mellitus after living donor kidney transplantation in Korea - a retrospective single center study.
Yu H; Kim H; Baek CH; Baek SD; Jeung S; Han DJ; Park SK
BMC Nephrol; 2016 Jul; 17(1):106. PubMed ID: 27473469
[TBL] [Abstract][Full Text] [Related]
13. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation.
Song JL; Gao W; Zhong Y; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG; Jiang L; Yang J
World J Gastroenterol; 2016 Feb; 22(6):2133-41. PubMed ID: 26877618
[TBL] [Abstract][Full Text] [Related]
14. Early occurrence of new-onset diabetes after transplantation is related to type of liver graft and warm ischaemic injury.
Hartog H; May CJ; Corbett C; Phillips A; Tomlinson JW; Mergental H; Isaac J; Bramhall S; Mirza DF; Muiesan P; Perera MT
Liver Int; 2015 Jun; 35(6):1739-47. PubMed ID: 25349066
[TBL] [Abstract][Full Text] [Related]
15. Effects of hyperglycemia on the development of new-onset diabetes after liver transplantation.
Anderson AL; Lewis DA; Steinke DT; Ranjan D; Smith KM; Clifford TM
Prog Transplant; 2009 Dec; 19(4):298-303. PubMed ID: 20050451
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for new-onset diabetes mellitus after kidney transplantation (NODAT): a Brazilian single center study.
Lima C; Grden A; Skare T; Jaworski P; Nisihara R
Arch Endocrinol Metab; 2018; 62(6):597-601. PubMed ID: 30624499
[TBL] [Abstract][Full Text] [Related]
17. New-onset diabetes mellitus developing in Asian adult living donor liver transplant recipients: a single-center experience.
Harada N; Sugawara Y; Akamatsu N; Kaneko J; Tamura S; Aoki T; Sakamoto Y; Hasegawa K; Yamashiki N; Kokudo N
J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):634-8. PubMed ID: 23564193
[TBL] [Abstract][Full Text] [Related]
18. New Onset Diabetes Mellitus in Living Donor versus Deceased Donor Liver Transplant Recipients: Analysis of the UNOS/OPTN Database.
Yadav AD; Chang YH; Aqel BA; Byrne TJ; Chakkera HA; Douglas DD; Mulligan DC; Rakela J; Vargas HE; Carey EJ
J Transplant; 2013; 2013():269096. PubMed ID: 24205434
[TBL] [Abstract][Full Text] [Related]
19. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
[TBL] [Abstract][Full Text] [Related]
20. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
